Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4400-4405

  Hardy, Dianne O ^a   Scher, Howard I ^a,b   Bogenreider, Thomas ^a,b   Sabbatini, Paul ^a,b   Zhang, Zuo Feng ^a,b   Nanus, David M ^a,b   Catterall, James F ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c POPULATION COUNCIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; DNA POLYMORPHISM; GROWTH REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FAMILY; TANDEM REPEAT; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REGRESSION ANALYSIS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0029848386     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4400     Document Type: Article

References (39)

1. Mangelsdorf DJ, Thummel C, Beato M, et al. 1995 The nuclear receptor superfamily: the second decade. Cell. 83:835-839.
2. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, et al. 1990 A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. 83:534-543.
3. Culig Z, Hobisch A, Cronauer MV, et al. 1993 Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol. 7:1541-1550.
4. Taplin ME, Bubley GJ, Shuster TD, et al. 1995 Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med. 332:1393-1398.
5. Takahashi H, Furusato M, Allsbrook WC, et al. 1995 Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men. Cancer Res. 332:1621-1624.
6. Kremer EJ, Pritchard M, Lynch M, et al. 1991 Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(GGG)n. Science. 252:1711-1714.
7. Verkerk AJMH, Pieretti M, Sutcliffe JS. 1991 Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:905-914.
8. Fu YH, Pizzuti A, Fenwick Jr RG, et al. 1992 An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 255:1256-1258.
9. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fishbeck KH. 1991 Androgen receptor gene mutations in X-linked spinal and bulbal muscular atrophy. Nature. 352:77-91.
10. Orr HT, Chung MY, Banfi S, et al. 1993 Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 4:221-226.
11. Huntington's Disease Collaborative Research Group. 1993 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:971-983.
12. Koide R, Ikeuchi I, Onodera O, et al. 1994 Expansion of an unstable trinucleotide CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DR-PLA). Nat Genet. 6:9-13.
13. Nagafuchi S, Yanagisawa H, Sato K, et al. 1994 Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet. 6:14-18.
14. La Spada AR, Paulson HL, Fischbeck KH. 1994 Trinucleotide repeat expansion in neurological disease. Ann Neurol. 36:814-822.
15. Chamberlain NL, Driver ED, Miesfield RL. 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:3181-3186.
16. Coetzee GA, Ross RK. 1994 Prostate cancer and the androgen receptor. J Natl Cancer Inst. 86:872-873.
17. Schroeder FF, Hermanek P, Denis L, et al. 1992 The TNM classification of prostatic carcinoma. Prostate. 4(Suppl):129-138.
18. Scher HI, Steineck G, Kelly WK. 1995 Hormone-refractory ("D.3") prostate cancer: refining the concept. Urology, 46:142-148.
19. Moreno JG, Croce CM, Fischer R, et al. 1992 Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52:6110-6112.
20. Nanus DM, Mentle IR, Matzer RJ, Bander NH, Albino, AF. 1990 Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol. 143:175-178.
21. Lubahn DB, Brown TR, Simental JA, et al. 1989 Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA. 86:9534-9538.
22. Allard MW, Ellsworth DL, Honeycutt RL. 1991 The production of single-stranded DNA suitable for sequencing using the polymerase chain reaction. Biotechniques. 10:24-26.
23. Innis MA, Myambo KB, Gelfand DH, Brow MA. 1988 DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci USA. 85:9436-9440.
24. Scheffe H. 1959 The analysis of variance. New York: Wiley and Sons.
25. Mehta CR, Patel NR. 1983 A network algorithm for performing Fischer's exact test in r X c contingency tables. J Am Statist Assoc. 78:427-434.
26. Draper N, Smith H. 1981 Applied regression analysis. New York: Wiley and Sons.
27. Kaplan EL, Meier P. 1958 Nonparametric estimation from incomplete observations. J Am Statist Assoc. 53:457-481.
28. Peto R, Pike MC, Armitage P, et al. 1977 Design and analysis of randomized trials requiring prolonged observation of each patient. II. Br J Cancer. 35:1-35.
29. SAS Institute. 1990 SAS/STAT user guide. Cary: SAS Institute.
30. Edwards A, Hammond HA, Jin L, Caskey CT, Chakraborty R. 1992 Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 12:241-253.
31. Schoenberg MP, Hakami JM, Wang S, et al. Microsatellite mutation (CAG24->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198:74-80.
32. Irvine RA, Yu MC, Ross RK, Coetzee GA. 1995 The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res. 55:1937-1940.
33. De Winter JAR, Trapman J, Brinkmann AO, et al. 1990 Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol. 161:329-332.
34. Newmark JR, Hardy EO, Tonb DC, et al. 1992 Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA. 89:6319-6323.
35. Culig Z, Klocker H, Eberle J, et al. 1993 DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate. 22:11-22.
36. Tilley WD, Lim-Tio SS, Horsfall DJ, et al. 1994 Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res. 54:4096-4102.
37. Tilley WD, Buchanan G, Hickey TE, Bentel JM. 1996 Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res. 2:277-285.
38. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Wilson JD. 1991 Androgen resistance caused by mutations in the androgen receptor gene. FASEB J. 5:2910-2915.
39. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson, JD. 1993 Genetic basis of endocrine disease. IV. The spectrum of mutations in theandrogen receptor gene that causes androgen resistance. J Clin Endocrinol Metab. 76:17-23.